Amerikaanse aandelen « Terug naar discussie overzicht

Hemispherx BioPharma, Inc (Public, AMEX:HEB)

13.337 Posts, Pagina: « 1 2 3 4 5 6 ... 45 46 47 48 49 50 51 52 53 54 55 ... 663 664 665 666 667 » | Laatste
welshterrier 5
0
was net al 1,72 hij gaat goed Crack of we het nou eens zijn of niet, even goede vrienden, ik sta lekker vet in de winst hier.
wat zeg ik 1,75 al, ik heb ruim 5 k dus elke 1 cent is bingo
[verwijderd]
0
quote:

Antonius86 schreef:

Haha inderdaad, je weet niet precies op welke 'toon' het bericht is geschreven...
Wij willen nieuws, wij willen nieuws, wij willen nieuws...........maar wel op de goede toon......))))
[verwijderd]
0
quote:

Horoz36 schreef:

[quote=Antonius86]
Haha inderdaad, je weet niet precies op welke 'toon' het bericht is geschreven...
[/quote]

Wij willen nieuws, wij willen nieuws, wij willen nieuws...........maar wel op de goede toon......))))
hehe.. neem aan dat je het woordje GOED er ook in wilt?
:p anders word het een ander toontje
[verwijderd]
0

Hemispherx Announces Payment of 2008 Executive Bonuses
On Wednesday May 27, 2009, 10:00 am EDT

PHILADELPHIA, May 27, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced today that on May 20, 2009, our Board of Directors awarded bonuses to the following executives in relation to 2008 corporate goals and objectives: W.A. Carter, M.D., CEO and Chairman of the Board, was awarded $300,000 and Dr. David Strayer, Chief Medical Officer, was awarded $150,000.

The Compensation Committee and Board of Directors reviewed corporate goals established in March 2008 and determined that significant progress has been made in terms of 1) preparation and filing the Ampligen(r) NDA with the Federal Drug Administration; and 2) with the receipt of recent funding for operating activities, funds previously reserved for operating activities could be used to pay 2008 bonus.

welshterrier 5
0
quote:

Antonius86 schreef:

Haha inderdaad, je weet niet precies op welke 'toon' het bericht is geschreven...
is op een goede toon geschreven, wanneer je op mij doelt tenminste. Ik ken Crack al jaren van het bio forum, leuke winsten gemaakt met Finisar en Insmed.
[verwijderd]
0
welsh: op die ene gaan we flink binnenhalen, houd hem maar op je watchlist

maar wel andere aantallen dan jouw trade positie in heb
welshterrier 5
0
quote:

crackedtooth schreef:

welsh: op die ene gaan we flink binnenhalen, houd hem maar op je watchlist

maar wel andere aantallen dan jouw trade positie in heb
Dat neem ik aan Crack volgens bij ben je al 4 jaar aan het bijkopen:-))) Insm
[verwijderd]
0
Nee welsh, ik had het niet expliciet over jou bericht maar over het algemeen als een bericht op een forum, msn gesprek of zelfs sms bericht leest dan snap je lang niet altijd op wat een toon die geschreven is..
welshterrier 5
0
ja dat is zo, cést le ton qui fait la musique.....

maar we blijven mooi liggen hier voorlopig en wanneer we door de 1,75 zijn kan het wel eens hard gaan
[verwijderd]
0
quote:

welshterrier schreef:

[quote=crackedtooth]
welsh: op die ene gaan we flink binnenhalen, houd hem maar op je watchlist

maar wel andere aantallen dan jouw trade positie in heb
[/quote]

Dat neem ik aan Crack volgens bij ben je al 4 jaar aan het bijkopen:-))) Insm
2 jaar positie welsh, enige over van een lijste van 10

en nu 2x zoveel aandelen als zomer geleden en zelfde voor zomer daarvoor

grootste positie nu en afgelopen maanden ook extra eea aan posities voor gesloten

kost op een andere manier tijd, maar payoff is groot als bedrijf slaagt en ook waarom biotech zo verdomd interessante sector is
welshterrier 5
0
Testimony to CFSAC meeting, May 27-28, 2009Posted by Mary Schweitzer on May 20, 2009 at 1:30pm
View Mary Schweitzer's blog
Testimony to the
Chronic Fatigue Syndrome Advisory Committee (CFSAC) of the
U.S. Department of Health and Human Services
United States Federal Government
Washington, D.C.

May 27, 2009

Mary M. Schweitzer, Ph.D.

Thank you for allowing me this time to speak.

First I need to catch everyone up with how my own case is going. As most of you know, I lost Ampligen fifteen months ago. I testified one year ago that I thought I would get twelve months before I relapsed, based on what happened when I voluntarily went off Ampligen in 2001. Unfortunately, I only had 9 months. I relapsed on Labor Day weekend, and three weeks later I was at Dr. Peterson’s being tested.

Some of the results were back by my October 2008 testimony. My VO2 MAX score had been normal the last time I was there; now it was 16 (very abnormal). I tested positive for EBV reactivation again, and I had a low natural killer cell count and function. In the past I have tested positive for HHV-6 and 37kDa Rnase-L, but they disappeared while on Ampligen and neither had reappeared yet.

Since then, I found that we can add cytomegalovirus (CMV) to the active viruses, and the September SPECT scan “demonstrated decreased activity in the left lateral temporal lobe and occipital lobes.” In February I had an abnormal Holter Monitor test that may or may not be related to the NMH/POTS I’ve known about since 1995.

My symptoms are much worse than they were a year ago. I have not driven a car since November (I get too confused). As you can see, I have to wear sunglasses indoors around bright lighting. I have problems with short-term memory, expressive dysphasia, ataxia – the full list of what I used to call my “encephalitic” symptoms. I spend a lot of time lying in bed in the dark, listening to a movie, but I also am able to go on internet for periods of time during the day. And my husband likes to throw me and the wheelchair in the car and get me to a baseball game a couple of times a week. (He took me to every Phillies World Series game in the wheelchair, with a blanket wrapped around me – glad he did.)

We tried Vistide, a strong antiviral recommended for CMV, but my liver rejected it. I am going to have a lumbar puncture soon. Dr. Peterson and the Whittemore-Peterson Institute have found they get more information from spinal fluid than from blood tests, and we can try to target the problems more precisely.

Although I am obviously unwell, I consider myself lucky. I am lucky because I have both private and public disability. I am lucky because I have very good Blue Cross/Blue Shield insurance through my husband. I am most lucky because my husband and family have stood by me all this time. My daughter sent me a bouquet of flowers for Mother’s Day – she wrote on the card, “I only wish it was a bouquet of Ampligen.”

What does a person do who is as sick as I am, without the help that I have? Where do they go? Working is not an option. I very quickly get incoherent. I walk so far, and then I stand there and fall over. I cannot work. So where would I be? On the street, I guess. You tell me.

I paid $20,000 a year for Ampligen – and would gladly do so again. But most of my friends live on far less. If I had only social security disability, I would be living on $9600 a year, like many of my friends. Try to figure out how to fit in rent, food, and some sort of transportation on that. A computer to link you with the outside world becomes a luxury. Medicine? Impossible. Nobody takes Medicare – and it doesn’t cover most of the tests I’ve had anyway.

For that matter, if you go to the CDC’s website for physician information on CFS, you won’t find any of the tests that have shown things physically wrong with me. They suggest the usual blood tests – I test normally on all of them. In fact, they list some of my testing – for HHV-6 or NMH/POTS, for example – as something not to give a patient with CFS. As they state in the beginning of the information packet, “There are no tests and there are no treatments.” That’s not been true for me – but then, I’ve often paid cash.

Ever since the cluster outbreaks of the mid-1980s, CDC has stood in the way of information about this disease. Despite the observations of specialists that the outbreaks appeared to be cases of Myalgic Encephalomyelitis (called Epidemic Neuromyesthenia at the time in the United States), the CDC insisted that it was a new disease entirely, chronic Epstein-Barr Virus. When CEBV became untenable (they should have stuck a little longer with that, as it turns out), they shifted to a name that sounded like CEBV without the virus – chronic mono syndrome = chronic fatigue syndrome.

Chronic as in “chronic complainer,” “fatigue” as in “yeah, I’ve been tired lately, too,” and “syndrome” as in “syndrome of the month.” A focus group could not have come up with a more dismissive name.

It was a gamble. Twenty years later, how has that gamble played out? Who is better off because they chose to name the disease “chronic fatigue syndrome” and ignore existing information about Myalgic Encephalomyelitis? It hasn’t helped patients – if anything, it has harmed us. But it does make it easier to characterize this disease as psychosomatic, “factitious,” even as neurasthenia by the very British psychiatrists the CDC hires as consultants on CFS. It makes it very easy to describe CFS as simply a collection of MUS (Medically Unexplained Symptoms). That has been a real boon to the insurance industry.

There is a group currently working on getting some form of the “MUS” category adopted in both ICD-11 and DMS-V – aiming right at us, patients diagnosed with CFS.

Thanks a lot for giving us that name.

Since 1996 I have attended and testified at almost every CFSCC and CFSAC meeting. But whenever we bring up evidence of biomarkers, physiological explanations of symptoms, or active viral onslaught, CDC has responded in every case by swatting it away like a gnat.

Here is the pattern. I take the train to Washington, I come to the meetings, I give my five minutes of testimony, and I pass out a written version. At first we were allowed more than five minutes, which was a kindness to people who have trouble speaking. We were even allowed to ask questions of the committee. But since 2003, it’s been five minutes only, and no questions to the committee from the gallery. Some of my previous testimony can be found on my website here:
www.cfids-me.org/marys/essays.html#cf...

I come and speak about having the Rnase-L Factor, and suggest that the test be made available. Bill Reeves of CDC would say, as soon as I was through, “It can’t be replicated.” That’s simply not true, but I didn’t have a microphone to be able to respond. In an NIH funded study, 98 of 100 patients from the Incline Village cluster outbreak tested positive for the 37kDa Rnase-L (it should weigh 80 kDa). 0f 100 patients with fibromyalgia, 100 with major melancholic depression, and 100 normals, only 2-3 percent tested positive in each of those three groups. That’s a pretty significant result.

Then the samples were sent, blinded, to two French researchers studying the same thing using a different method. They correctly identified each sample. I would call that replication. Two countries, two methods, same sample. 100 CFS patients and 300 controls. That’s repl
welshterrier 5
0
[verwijderd]
0
ze zeggen dat hij niet de 1.41 heeft geraakt in die periode en dus geluk heb dat ik alsnog een plukje van 900 heb kunnen bemachtigen. Ik heb de deeluitvoer laten royeren en alsnog bijgekocht rond de 1.55. 2900 stuks nu.
[verwijderd]
0
blijft lekker hangen, super...
alleen tja nu nog een goedkeuring ;-)

zo net thuis, effe beetje bijlezen nu, met een bakje erbij ...
[verwijderd]
0
quote:

roos1971 schreef:

blijft lekker hangen, super...
alleen tja nu nog een goedkeuring ;-)

zo net thuis, effe beetje bijlezen nu, met een bakje erbij ...
lees jij wat nieuws?
13.337 Posts, Pagina: « 1 2 3 4 5 6 ... 45 46 47 48 49 50 51 52 53 54 55 ... 663 664 665 666 667 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
911,34  +0,62  +0,07%  07 mrt
 Germany40^ 23.212,60 -0,88%
 BEL 20 4.469,34 +0,13%
 Europe50^ 5.520,52 +0,95%
 US30^ 42.798,70 0,00%
 Nasd100^ 20.187,80 0,00%
 US500^ 5.768,30 0,00%
 Japan225^ 37.281,60 0,00%
 Gold spot 2.909,90 0,00%
 EUR/USD 1,0836 +0,03%
 WTI 66,99 0,00%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

ACOMO +9,95%
Kendrion +8,38%
CM.COM +6,94%
WDP +5,16%
Accsys +3,28%

Dalers

AMG Critical ... -7,95%
ArcelorMittal -5,25%
Air France-KLM -4,93%
ADYEN NV -4,15%
TomTom -3,57%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront